{
 "ticker": "ETHO",
 "name": "Amplify Etho Climate Leadership U.S. ETF",
 "issuer": "Amplify",
 "desk": "themes",
 "url": "https://etfiq.com/funds/etho",
 "html": "https://etfiq.com/funds/etho",
 "markdown": "https://etfiq.com/funds/etho.md",
 "as_of": "2026-09-18",
 "verdict": "ETHO holds 287 stocks, and 74% of its weight is outside the S&P 500.",
 "key_facts": [
  {
   "key": "already_in_the_s_p_500",
   "label": "Already in the S&P 500",
   "value": "25.6%",
   "source": null,
   "as_of": "2026-09-18",
   "sentence": "ETHO, already in the S&P 500: 25.6%, as of Sep 18, 2026."
  },
  {
   "key": "active_share_vs_the_s_p_500",
   "label": "Active share vs the S&P 500",
   "value": "90.9%",
   "source": null,
   "as_of": "2026-09-18",
   "sentence": "ETHO, active share vs the S&P 500: 90.9%, as of Sep 18, 2026."
  },
  {
   "key": "top_ten_holdings",
   "label": "Top ten holdings",
   "value": "8.2%",
   "source": null,
   "as_of": "2026-09-18",
   "sentence": "ETHO, top ten holdings: 8.2%, as of Sep 18, 2026."
  },
  {
   "key": "total_return_1_year",
   "label": "Total return, 1 year",
   "value": "+23.7%",
   "source": null,
   "as_of": "2026-09-18",
   "sentence": "ETHO, total return, 1 year: +23.7%, as of Sep 18, 2026."
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$191m",
   "source": "issuer page, as of Sep 18, 2026",
   "as_of": "2026-09-18",
   "sentence": "ETHO, net assets: $191m (issuer page, as of Sep 18, 2026)."
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.45%",
   "source": "485BPOS XBRL, Jan 28, 2026",
   "as_of": "2026-09-18",
   "sentence": "ETHO, expense ratio: 0.45% (485BPOS XBRL, Jan 28, 2026)."
  }
 ],
 "fields": [
  {
   "key": "theme",
   "label": "Theme",
   "value": "Energy transition and decarbonisation",
   "source": "ETFIQ, editorial"
  },
  {
   "key": "launched",
   "label": "Launched",
   "value": "Jan 29, 2024",
   "source": null
  },
  {
   "key": "already_in_the_s_p_500_by_weight",
   "label": "Already in the S&P 500, by weight",
   "value": "25.6%",
   "source": "ETFIQ"
  },
  {
   "key": "active_share_vs_the_s_p_500",
   "label": "Active share vs the S&P 500",
   "value": "90.9%",
   "source": "ETFIQ"
  },
  {
   "key": "already_in_the_nasdaq_100_by_weight",
   "label": "Already in the Nasdaq-100, by weight",
   "value": "8.0%",
   "source": "ETFIQ"
  },
  {
   "key": "active_share_vs_the_nasdaq_100",
   "label": "Active share vs the Nasdaq-100",
   "value": "93.0%",
   "source": "ETFIQ"
  },
  {
   "key": "top_ten_holdings_weight",
   "label": "Top ten holdings weight",
   "value": "8.2%",
   "source": null
  },
  {
   "key": "holdings",
   "label": "Holdings",
   "value": "287",
   "source": null
  },
  {
   "key": "holdings_published_for",
   "label": "Holdings published for",
   "value": "Sep 21, 2026",
   "source": "the issuer\u2019s daily file"
  },
  {
   "key": "top_holdings",
   "label": "Top holdings",
   "value": "MaxLinear Inc 1.4%, 10X Genomics Inc 1.1%, Corcept Therapeutics Inc 0.8%, SELLAS Life Sciences Group Inc 0.8%, Personalis Inc 0.8%, Aehr Test Systems 0.8%, Semtech Corp 0.7%, Okta Inc 0.7%, Magnite Inc 0.6%, Adaptive Biotechnologies Corp 0.6%",
   "source": null
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$191m",
   "source": "issuer page, as of Sep 18, 2026"
  },
  {
   "key": "below_its_all_time_high",
   "label": "Below its all-time high",
   "value": "\u22125.1%",
   "source": "ETFIQ"
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.45%",
   "source": "485BPOS XBRL, Jan 28, 2026"
  },
  {
   "key": "fee_for_the_part_that_differs_from_the_s_p_500_active_expense_ratio",
   "label": "Fee for the part that differs from the S&P 500, active expense ratio",
   "value": "0.50%",
   "source": "ETFIQ"
  },
  {
   "key": "closest_funds_by_holdings_overlap",
   "label": "Closest funds by holdings overlap",
   "value": "TRFM 12%, USNZ 10%",
   "source": null
  }
 ],
 "periods": [
  {
   "window": "3 months",
   "Total return": "+2.2%",
   "S&P 500": "+2.3%",
   "Gap to S&P 500": "\u22120.1 pts",
   "Gap to Nasdaq-100": "+4.7 pts"
  },
  {
   "window": "6 months",
   "Total return": "+22.1%",
   "S&P 500": "+18.0%",
   "Gap to S&P 500": "+4.1 pts",
   "Gap to Nasdaq-100": "\u22122.1 pts"
  },
  {
   "window": "1 year",
   "Total return": "+23.7%",
   "S&P 500": "+16.6%",
   "Gap to S&P 500": "+7.2 pts",
   "Gap to Nasdaq-100": "+2.0 pts"
  },
  {
   "window": "Since launch",
   "Total return": "+44.9%",
   "S&P 500": "+60.1%",
   "Gap to S&P 500": "\u221215.2 pts",
   "Gap to Nasdaq-100": "\u221225.9 pts"
  }
 ],
 "questions": [
  {
   "q": "How much of ETHO is in S&P 500 companies?",
   "a": "By its holdings published by its issuer for Sep 21, 2026, 26% of ETHO by weight is stocks the S&P 500 already holds. Its active share against the index is 91%, so that share is the part doing something different."
  },
  {
   "q": "What does ETHO hold?",
   "a": "287 positions as published by its issuer for Sep 21, 2026, with the top ten at 8% of the fund. The largest are MaxLinear Inc at 1.4%, 10X Genomics Inc at 1.1%, Corcept Therapeutics Inc at 0.8%."
  },
  {
   "q": "Has ETHO beaten the S&P 500?",
   "a": "Over the year to Sep 18, 2026 ETHO returned +23.7% with distributions reinvested, against +16.6% for the S&P 500, so it finished ahead of the index by 7.2 points."
  },
  {
   "q": "What does ETHO cost?",
   "a": "The prospectus expense ratio is 0.45% a year. Because 91% of the fund differs from the S&P 500, the fee on that differing part works out at 0.50%."
  }
 ],
 "generated": "2026-09-21",
 "license": "Free to use with attribution. ETFIQ (etfiq.com)."
}